CSF 5-HIAA and DST non-suppression - Orthogonal biologic risk factors for suicide in male mood disorder inpatients

Psychiatry Research

Volumn 165, Issue 1-2, 2009, Pages 96-102

  Jokinen, Jussi ^a   Nordström, Anna Lena ^a   Nordström, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CSF 5 HIAA; Depressive disorder; Dexamethasone suppression test; HPA axis; Prediction; Serotonin; Suicide

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIDEPRESSANT AGENT; DEXAMETHASONE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEATH CERTIFICATE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; RISK FACTOR; SUICIDE; SUICIDE ATTEMPT;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CAUSE OF DEATH; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DYSTHYMIC DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SUICIDE; SWEDEN;

EID: 57649240021     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.10.007     Document Type: Article

References (40)

1. Amsel L., and Mann J.J. Suicide risk assessment and the suicidal process approach. In: van Heeringen K. (Ed). Understanding Suicidal Behaviour: The Suicidal Process Approach to Research and Treatment (2001), John Wiley and Sons, Ltd, Sussex 163-181
2. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., Hoogendijk W.J., Tijssen J.G., Wiersinga M.W., and Schene A.H. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major mepression). Biological Psychiatry 59 8 (2006) 696-701
3. Åsberg M., Träskman L., and Thorén P. 5-HIAA in the cerebrospinal fluid: a biological suicide predictor?. Archives of General Psychiatry 33 (1976) 1193-1197
4. Bertilsson L. Quantitative mass fragmentography - a valuable tool in clinical pharmacology. In: Usdin E. (Ed). Clinical Pharmacology in Psychiatry (1981), Elsevier, New York 59-72
5. Brouwer J.P., Appelhof B.C., van Rossum E.F., Koper J.W., Fliers E., Huyser J., Schene A.H., Tijssen J.G., Van Dyck R., Lamberts S.W., Wiersinga W.M., and Hoogendijk W.J. Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression. Psychoneuroendocrinology 31 10 (2006) 1154-1163
6. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Research Review. 18 (1993) 1-32
7. Chaouloff F. Serotonin, stress and corticoids. Journal of Psychopharmacology 14 (2000) 139-151
8. Coryell W., and Schlesser M. The dexamethasone suppression test and suicide prediction. American Journal of Psychiatry 158 (2001) 748-753
9. Coryell W., Young E., and Carroll B. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Research 142 1 (2006) 99-104
10. Coryell W., and Schlesser M. Combined biological tests for suicide prediction. Psychiatry Research 150 2 (2007) 187-191
11. Fawcett J., Busch K.A., Jacobs D., Kravitz H.M., and Fogg L. Suicide: a four-pathway clinical-biochemical model. Annals of the New York Academy of Sciences 836 (1997) 288-301
12. Harris E.C., and Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. British Journal of Psychiatry 170 (1997) 205-228
13. Isacsson G. Depression is the core of suicidality - its treatment is the cure. Acta Psychiatrica Scandinavica 114 (2006) 149-150
14. Jokinen J., Carlborg A., Martensson B., Forslund K., Nordstrom A.L., and Nordstrom P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Research 150 3 (2007) 297-303
15. Jokinen, J., Nordstrom, A.L., Nordstrom, P., 2008a. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. Journal of Affective Disorders 106 (1-2), 145-152.
16. Jokinen, J., Martensson, B., Nordstrom, A.L., Nordstrom, P., 2008b. CSF 5-HIAA and DST non-suppression-independent biomarkers in suicide attempters? Journal of Affective Disorders 105 (1-3), 241-245.
17. Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28 (1995) 77-79
18. Mann J.J. Neurobiology of suicidal behaviour. Nature Review Neuroscience 4 (2003) 819-828
19. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., and Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. International Journal of Neuropsychopharmacology 21 (2006) 1-10
20. Mann J.J., and Currier D. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Archives of Suicide Research 11 1 (2007) 3-16
21. McAllister-Williams R.H., Ferrier I.N., and Young A.H. Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychological Medicine 28 (1998) 573-584
22. Meijer O.C., and De Kloet E.R. Corticosterone and serotonergic neurotransmission in the hippocampus: functional implications of central corticosteriod receptor diversity. Critical Reviews in Neurobiology 12 (1998) 1-20
23. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., and Anisman H. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. Journal of Neuroscience 24 (2004) 1478-1485
24. Norman W.H., Brown W.A., Miller I.W., Keitner G.I., and Overholser J.C. The dexamethasone suppression test and completed suicide. Acta Psychiatrica Scandinavica 81 (1990) 120-125
25. Nordström P., Samuelsson M., Åsberg M.M., Traskman-Bendz L., Aberg-Wistedt A., Nordin C., and Bertilsson L. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide and Life Threatening Behavior 24 (1994) 1-9
26. Nordström P., Samuelsson M., and Åsberg M. Survival analysis of suicide risk after attempted suicide. Acta Psychiatrica Scandinavica 91 (1995) 336-340
27. Oquendo M.A., Currier D., and Mann J.J. Prospective studies of suicidal behavior in major depressive and bipolar disorders: what is the evidence for predictive risk factors?. Acta Psychiatrica Scandinavica 114 (2006) 151-158
28. Owens D., Horrocks J., and House A. Fatal and non-fatal repetition of self-harm: systematic review. British Journal of Psychiatry 181 (2002) 193-199
29. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 49 (2001) 391-404
30. Porter R.J., Gallagher P., Watson S., and Young A.H. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 173 1-2 (2004) 1-17
31. Pfennig A., Kunzel H.E., Kern N., Ising M., Majer M., Fuchs B., Ernst G., Holsboer F., and Binder E.B. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biological Psychiatry 57 (2005) 336-342
32. Rogers J., Martin L.J., Comuzzie A.G., Mann J.J., Manuck S.B., Leland M., and Kaplan J.R. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Biological Psychiatry 55 (2004) 739-744
33. Roy A., De Jong J., and Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Archives of General Psychiatry 46 (1989) 609-612
34. Samuelsson M., Jokinen J., Nordstrom A.L., and Nordstrom P. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatrica Scandinavica 113 1 (2006) 44-47
35. Suominen K., Isometsa E., Suokas J., Haukka J., Achte K., and Lonnqvist J. Completed suicide after a suicide attempt: a 37-year follow-up study. American Journal of Psychiatry 161 3 (2004) 562-563
36. Träskman L., Asberg M., Bertilsson L., and Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry 38 (1981) 631-636
37. Träskman-Bendz L., Alling C., Oreland L., Regnell G., Vinge E., and Öhman R. Prediction of suicidal behavior from biologic tests. Journal of Clinical Psychopharmacology 12 Suppl. (1992) 21 S-26 S
38. Wasserman, D., Sokolowski, M., Rozanov, V., Wasserman, J., 2008. The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes, Brain, and Behavior 7 (1), 14-19.
39. Westrin A., and Nimeus A. The dexamethasone suppression test and CSF-5-HIAA in relation to suicidality and depression in suicide attempters. European Psychiatry 18 4 (2003) 166-171
40. Yerevanian B.I., Feusner J.D., Koek R.J., and Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. Journal of Affective Disorders 83 (2004) 103-108